Form EFFECT Day One Biopharmaceutica
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Day One Biopharmaceuticals (DAWN) IPO Opens 56% Higher
May 27, 2021 11:39 AM EDTToday's IPO for Day One Biopharmaceuticals (NASDAQ: DAWN) opened for trading at $25 after pricing 10,000,000 shares of its common stock at a public offering price of $16.00 per share.
J.P. Morgan, Cowen and Piper Sandler are acting as joint bookrunning managers for the offering. Wedbush PacGrow is acting as lead manager for the offering.
Day One is... More
